Literature DB >> 2068169

Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.

R C Seeger1, J G Villablanca, K K Matthay, R Harris, T J Moss, S A Feig, M Selch, N Ramsay, C P Reynolds.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2068169

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  5 in total

1.  The strategy to treat disseminated neuroblastoma utilizing bone marrow transplantation: what is the surgeon's role?

Authors:  S Yokoyama; H Hirakawa; J Soeda; S Ueno; T Tajima; T Mitomi; H Yabe; M Yabe; S Kato
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 2.  High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Authors:  Bilgehan Yalçin; Leontien C M Kremer; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-10-05

3.  A single center clinical analysis of children with high-risk neuroblastoma.

Authors:  Xiangdong Tian; Yanna Cao; Jingfu Wang; Jie Yan; Yao Tian; Zhongyuan Li; Huijuan Wang; Xiaofeng Duan; Yan Jin; Qiang Zhao
Journal:  Oncotarget       Date:  2017-05-02

4.  Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.

Authors:  T Philip; R Ladenstein; J M Zucker; R Pinkerton; E Bouffet; D Louis; W Siegert; J L Bernard; D Frappaz; C Coze
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

5.  Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma.

Authors:  A Pession; A Prete; F Locatelli; S Pierinelli; A L Pession; R Maccario; E Magrini; B De Bernardi; P Paolucci; G Paolucci
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.